"10.1371_journal.pone.0019621","plos one","2011-05-10T00:00:00Z","Camille Pelat; Alessandra Falchi; Fabrice Carrat; Anne Mosnier; Isabelle Bonmarin; Clément Turbelin; Sophie Vaux; Sylvie van der Werf; Jean Marie Cohen; Bruno Lina; Thierry Blanchon; Thomas Hanslik","UPMC Université Paris 06, UMRS 707, Paris, France; U707, INSERM, Paris, France; Unité de Santé Publique, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France; Réseau des GROG, Groupes Régionaux dObservation de la Grippe, Paris, France; Institut de Veille Sanitaire, Saint-Maurice, France; Unit of Molecular Genetics of RNA Viruses, National Influenza Center (Northern-France), Department of Virology, Institut Pasteur, Paris, France; URA3015, CNRS, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Laboratoire de Virologie, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, CNR des Virus Influenzae - Région Sud, Bron, France; Service de Médecine Interne, Hôpital Ambroise-Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France","Conceived and designed the experiments: CP FC AM TB TH. Performed the experiments: AF SvdW JMC BL. Contributed reagents/materials/analysis tools: IB CT SV. Wrote the paper: CP FC AM TB TH AF.","Several authors have competing interests, unrelated to the submitted study: SVDW has had a conference invitation from GSK; a research grant from GSK on an unrelated subject; joined patent from institution with GSK on an unrelated subject: vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV&rpar; infection and their use in the prevention of SARS (patent US 2010/0233250 A1, published September 16 2010); travel grants for meetings from GSK; contributed to a clinical trial financed by Roche; is a member of the advisory committee on influenza of the French ministry of health; is a member of ESWI; is a member of the scientific committee of the GEIG; and is vice-president of the GROG network. BL has had paid consultancy and board membership (Roche, GSK, Novartis, BioCryst, MedImmune); has had research grants from Roche and Sanofi-Pasteur; and has received travel grants and honoraria for speaking or participation at meetings (Roche, Sanofi-Pasteur). TB has had a conference invitation from Roche in 2010 and is a member of the scientific committee of the GEIG. JMC has involvement in some epidemiological studies partially or fully granted by Roche and GSK, and travel grants from Roche for participation in scientific meetings. AM has a membership in the ministry of health advisory board on influenza; involvement in some epidemiological studies partially or fully granted by Roche and GSK; and travel grants from Roche for participation in scientific meetings. FC was a consultant for Novartis and GSK. The other authors have declared that no competing interests exist.","2011","05","Camille Pelat","CP",12,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
